Shares of Dendreon (Nasdaq: DNDN) are trading significantly higher ... But how much room is left to run in the stock? Is …
Many investors appear to be quite bearish on Dendreon Corporation (DNDN), especially if you look at the percentage of the float that is sold short for this stock. Currently, 26.92% of the float is sold short, suggesting an extreme level of …
Dendreon Corporation ( DNDN) reported fourth-quarter 2011 earnings (including stock-based compensation expense but excluding other special items) of 37 cents per share, in contrast to the Zacks Consensus Estimate loss of 31 cents …
I talked to Greg Schiffman, Dendreon’s CFO, this morning on the company’s announcement that it would raise about $46 million, after fees, by selling some of its stock to an institutional investor. Below are some highlights of that interview.
Trading on Dendreon /quotes/zigman/83175 /quotes/nls/dndn DNDN was halted and restrictions on short sales for the stock were triggered in an effort to keep shares from falling further. The move was initiated after Dendreon reported a …
“Dendreon announced a much-anticipated facility shut-down, although the Street was not expecting the closing of the company’s largest manufacturing facility,” said Barclays analyst Ying Huang in a note, halving the price target on the …
Many investors appear to be quite bearish on Dendreon Corporation (DNDN), especially if you look at the percentage of the float that is sold short for this stock. Currently, 26.96% of the float is sold short, suggesting an extreme level of …
An analyst apologized to clients late Wednesday for his calls on troubled biotechnology company Dendreon Corp., as he moved his rating on the shares to hold from buy in the wake of the company lowering sales estimates for the coming …
As previously announced, on November 10, 2014, Dendreon Corporation (OTCBB ... letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, in accordance with Nasdaq Listing Rules …